Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Falciparum Malaria
Interventions
DRUG

Artesunate

Artesunate 2 mg/kg/day for 7 days

DRUG

Artesunate + Mefloquine

Artesunate 4mg/kg/day for 3 days plus mefloquine 15mg/kg on day 3 and 10mg/kg on day 4

Trial Locations (1)

Unknown

Pailin Referal Hospital, Pailin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

NCHADS - Ministry of Health of Cambodia

OTHER

collaborator

Mahidol University

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

FHI 360

OTHER

collaborator

Li Ka Shing Foundation

OTHER

lead

University of Oxford

OTHER